* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 130℃; for 0.5h;microwave irradiation;
Intermediate 5: 1 ,1-Dimethylethyl (3 ~)-3-fr(7-chloropyridor3,4-blpyrazin-5- yl)amino1methviyi-piperidinecarboxylate; 5,7-dichloropyrido[3,4-b]pyrazine (1g, 5.00mmol) was taken up in N-Methyl-2- pyrrolidone (NMP) (10ml) and treated with 1 , 1-dimethylethyl (3f~)-3-(aminomethyl)-1- piperidinecarboxylate (1.179g, 5.50mmol) (Apollo Scientific Ltd) and diisopropylethylamine (1.310ml, 7.50mmol). The reaction was irradiated in a Biotage microwave at 130C for 30min. The reaction was partitioned between EtOAc (100ml) and water (100ml). The organic layer was washed with brine (100ml), dried using a hydrophobic frit and concentrated to give a black solid. This solid was purified on silica (50g) and eluted with a 10-40% EtOAc/cyclohexane gradient. The appropriate fractions were combined and concentrated to give the title compound as a deep orange solid (1.542g).LCMS (Method B): Rt = 1.28min, MH+ = 377.92
1.542 g
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 130℃; for 0.5h;Microwave irradiation;
Intermediate 5: 1,1-Dimethylethyl (3R)-3-[(7-chloropyrido[3,4-b]pyrazin-5-yl)amino]methyl}-1-piperidinecarboxylate 5,7-dichloropyrido[3,4-b]pyrazine (1 g, 5.00 mmol) was taken up in N-Methyl-2-pyrrolidone (NMP) (10 ml) and treated with <strong>[140645-23-4]1,1-dimethylethyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate</strong> (1.179 g, 5.50 mmol) (Apollo Scientific Ltd) and diisopropylethylamine (1.310 ml, 7.50 mmol). The reaction was irradiated in a Biotage microwave at 130 C. for 30 min. The reaction was partitioned between EtOAc (100 ml) and water (100 ml). The organic layer was washed with brine (100 ml), dried using a hydrophobic frit and concentrated to give a black solid. This solid was purified on silica (50 g) and eluted with a 10-40% EtOAc/cyclohexane gradient. The appropriate fractions were combined and concentrated to give the title compound as a deep orange solid (1.542 g). LCMS (Method B): Rt=1.28 min, MH+=377.92
With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; at 20℃; for 4h;
A) (S)-terf-butyl 3-((7-chloropyrido[4,3-ib]pyrazi n-5-ylami no)methyl)piperidi ne- 1 -carboxylate.A solution of (S)-teri-butyl 3-(aminomethyl)piperidine-1 -carboxylate (100 mg, 0.5 mmol), 5,7-dichloropyrido[4,3-￡>]pyrazine (100 mg, 0.5 mmol) and DIPEA (77 mg, 0.6 mmol) in THF (5 mL) was stirred at room temperature for 4 hours. The volatiles were removed under reduced pressure, and the residue was treated with ethyl acetate, with brine, and concentrated to give the crude title compound.
With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; at 20℃; for 4h;
(A) (S)-terf-butyl 3-((7-chloropyrido[4,3-ib]pyrazi n-5-ylami no)methyl)piperidi ne- 1 -carboxylate.[0123] A solution of (S)-teri-butyl 3-(aminomethyl)piperidine-1 -carboxylate (100 mg, 0.5 mmol), 5,7-dichloropyrido[4,3-￡>]pyrazine (100 mg, 0.5 mmol) and DIPEA (77 mg, 0.6 mmol) in THF (5 ml_) was stirred at room temperature for 4 hours. The volatiles were removed under reduced pressure, and the residue was treated with ethyl acetate, with brine, and concentrated to give the crude title compound.
With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; at 20℃; for 4h;
A solution of <strong>[140645-24-5](S)-tert-butyl 3-(aminomethyl)piperidine-1-carboxylate</strong> (100 mg, 0.5 mmol), 5,7-dichloropyrido[4,3-b]pyrazine (100 mg, 0.5 mmol) and DIPEA (77 mg, 0.6 mmol) in THF (5 mL) was stirred at room temperature for 4 hours. The volatiles were removed under reduced pressure, and the residue was treated with ethyl acetate, with brine, and concentrated to give the crude title compound.
Chemistry
Pharmaceutical Intermediates
Inhibitors/Agonists
Material Science
For Research Only
120K+ Compounds
Competitive Price
1-2 Day Shipping
